Menu Search
Equities

Lotus Eye Hospital and Institute Ltd

LOTUSEYE:NSI

Lotus Eye Hospital and Institute Ltd

Actions
Health CareHealth Care Providers
  • Price (INR)56.45
  • Today's Change0.85 / 1.53%
  • Shares traded27.60k
  • 1 Year change-27.67%
  • Beta0.4056
Data delayed at least 15 minutes, as of Jun 07 2024 11:01 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Lotus Eye Hospital and Institute Limited is an India-based company, which is engaged in the business of healthcare activities. The Company operates primarily in the field of ophthalmology (Eye) and its related operations. It resolves a range of eye problems, such as refractive, cataract, cornea infections, ocular prosthesis, orbit and oculoplasty, glaucoma, keratoconus, computer vision syndrome, neuro ophthalmology, retinal disease/diabetic eye care, UVEA and ocular inflammation, zyoptix-ultimate, and binocular vision. The Company provides treatments through ReLEx SMILE, Lasik Eye Surgery, Epi-LASIK, Intralase, Supracor, Robotic Femto Laser Cataract Surgery (LRCS), Phacoemulsification, Paediatric Eye Care and Squint Surgery, and Micro Incision Cataract Surgery (MICS). The Company operates approximately seven centers at Peelamedu, R.S. Puram, Mettupalayam, Tirupur, Salem, Cochin, and Mulanthurthy.

  • Revenue in INR (TTM)482.10m
  • Net income in INR29.15m
  • Incorporated1997
  • Employees209.00
  • Location
    Lotus Eye Hospital and Institute Ltd770/12 Avinashi Road, Civil Aerodrome post,COIMBATORE 641014IndiaIND
  • Phone+91 4 224229999
  • Fax+91 4 222627193
  • Websitehttps://www.lotuseye.org/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.